HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NACDS Marketplace In Brief

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal: Shipping in July, Collagen Micro-Pulse is a two-step "total eye correction system," introduced at the National Association of Chain Drugstores Marketplace June 5-8 in San Diego, Calif. "Inspired by professional medical techniques," the product consists of a 0.5-oz. anti-aging cream and a battery-operated "micro-pulsating" massager. The cream contains Erasyl to minimize dark circle pigments for brighter eyes and collagen to smooth under-eye wrinkles and crow's feet, while the massager reduces puffiness and under-eye bags and stimulates circulation. L'Oreal says immediately after use, crow's feet will appear smoother and eye bags will appear reduced. Clinical testing supports longer-term results, firm notes. In the U.K., L'Oreal retails a similar product, Dermo Expertise Collagen Micro-Vibration, at Boots for £16.99. Collagen Micro-Pulse will retail for $19.99
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS016993

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel